abstract |
The compound of formula (I) in which R, R, R, R, R, R, R, R, R, R, X and Y are as defined in the text of the application, or tautomer, prodrug, solvate or salt of this compound; pharmaceutical compositions containing such compounds, a method of modulating the functioning of the glucocorticoid receptor, as well as methods for treating diseases or conditions mediated by the functioning of the glucocorticoid receptor, or characterized by the presence of inflammatory, allergic or proliferative processes in the patient's body, using such compounds. The international application was published along with an international search report. |